← Open Payments lookup

MISHELL KERR: Open Payments

NPI 1023460318 · NORMAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$514 in 27 payments from 10 companies in 2025. Trend: 2023 $708 · 2024 $803 · 2025 $514

Food & beverage: $514
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP7$146
ABBVIE INC.4$75
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$53
Almatica Pharma LLC2$52
Esperion Therapeutics, Inc.3$50
Bayer Healthcare Pharmaceuticals Inc.2$35
Lilly USA, LLC2$32
Axsome Therapeutics, Inc.2$31
Ascendis Pharma Endocrinology Inc1$26
Amgen Inc.1$14

Products named: VRAYLAR, FARXIGA, CAPLYTA, BREZTRI, TERIPARATIDE, NEXLETOL, Kerendia, AIRSUPRA.

Industry payments across OK — which companies pay providers there.